HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Albers, J. J. Articles by Adolphson, J. L. Search for Related Content PubMed PubMed Citation Articles by Albers, J. J. Articles by Adolphson, J. L. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 29, 102-108, Copyright © 1988 by Lipid Research, Inc.

ARTICLES

Comparison of commercial kits for apoprotein A-I and apoprotein B with standardized apoprotein A-I and B radioimmunoassays performed at the Northwest Lipid Research Center

JJ Albers and JL Adolphson
Department of Medicine and Pathology, University of Washington School of Medicine, Seattle 98104.

There has recently been a proliferation of commercial kits available for apoproteins A-I and B. Since reference procedures for apoproteins have not yet been established we have elected to compare apoprotein kit methods with highly standardized apoprotein B and A-I radioimmunoassays developed at the Northwest Lipid Research Center. Commercial radial immunodiffusion kits for apoproteins A-I and B were obtained from three separate companies, Calbiochem, Daiichi Pure Chemicals, and Tago, and a commercial radioimmunoassay kit for apoprotein A-I was obtained from Ventrex Laboratories. Considerable differences were observed between the commercial kit methods and the Northwest Lipid Research radioimmunoassay methods. Some of the differences between methods were related to the assigned value of the reference materials. Other differences between methods were clearly method-dependent.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. L.E. Klos, C. F. Sing, E. Boerwinkle, S. C. Hamon, T. J. Rea, A. Clark, M. Fornage, and J. E. Hixson Consistent Effects of Genes Involved in Reverse Cholesterol Transport on Plasma Lipid and Apolipoprotein Levels in CARDIA Participants Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1828 - 1836. [Abstract] [Full Text] [PDF]

				M. Gross, X. Yu, P. Hannan, C. Prouty, and D. R Jacobs Jr Lipid standardization of serum fat-soluble antioxidant concentrations: the YALTA study Am. J. Clinical Nutrition, February 1, 2003; 77(2): 458 - 466. [Abstract] [Full Text] [PDF]

				S.-H. H. Juo, Z. Han, J. D. Smith, L. Colangelo, and K. Liu romoter polymorphisms of hepatic lipase gene influence HDL2 but not HDL3 in African American men: CARDIA study J. Lipid Res., February 1, 2001; 42(2): 258 - 264. [Abstract] [Full Text]

				S.-H. H. Juo, Z. Han, J. D. Smith, L. Colangelo, and K. Liu Common Polymorphism in Promoter of Microsomal Triglyceride Transfer Protein Gene Influences Cholesterol, ApoB, and Triglyceride Levels in Young African American Men : Results From the Coronary Artery Risk Development in Young Adults (CARDIA) Study Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1316 - 1322. [Abstract] [Full Text] [PDF]